These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26733255)

  • 1. Magnetic sentinel lymph node biopsy in a murine tumour model.
    Ahmed M; Woo T; Ohashi K; Suzuki T; Kaneko A; Hoshino A; Zada A; Baker R; Douek M; Kusakabe M; Sekino M
    Nanomedicine; 2016 May; 12(4):1045-1052. PubMed ID: 26733255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.
    Pouw JJ; Grootendorst MR; Bezooijen R; Klazen CA; De Bruin WI; Klaase JM; Hall-Craggs MA; Douek M; Ten Haken B
    Br J Radiol; 2015; 88(1056):20150634. PubMed ID: 26492466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
    Alvarado MD; Mittendorf EA; Teshome M; Thompson AM; Bold RJ; Gittleman MA; Beitsch PD; Blair SL; Kivilaid K; Harmer QJ; Hunt KK
    Ann Surg Oncol; 2019 Oct; 26(11):3510-3516. PubMed ID: 31297674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast MRI in patients after breast conserving surgery with sentinel node procedure using a superparamagnetic tracer.
    Christenhusz A; Pouw JJ; Simonis FFJ; Douek M; Ahmed M; Klaase JM; Dassen AE; Klazen CAH; van der Schaaf MC; Ten Haken B; Alic L
    Eur Radiol Exp; 2022 Jan; 6(1):3. PubMed ID: 35083595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of low dose superparamagnetic iron oxide tracer for sentinel node biopsy in breast conserving treatment on susceptibility artefacts on magnetic resonance imaging and contrast enhanced mammography.
    van Haaren ERM; Spiekerman van Weezelenburg MA; van Bastelaar J; Janssen A; van Nijnatten T; Bouwman LH; Vissers YLJ; Lobbes MBI
    Surg Oncol; 2024 Apr; 53():102045. PubMed ID: 38330805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoiding unnecessary sentinel lymph node biopsy with the use of superparamagnetic iron oxide mapping agents (Magtrace®) in breast surgery.
    Cui RBJ; Hawes S; Azimi F; Chan B; Graham S; Mak C; Seah JL; Warrier S
    ANZ J Surg; 2024 Jun; 94(6):1090-1095. PubMed ID: 38456358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study.
    Shiozawa M; Kobayashi S; Sato Y; Maeshima H; Hozumi Y; Lefor AT; Kurihara K; Sata N; Yasuda Y
    Breast Cancer; 2014 Jul; 21(4):394-401. PubMed ID: 22926506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers.
    Krischer B; Forte S; Niemann T; Kubik-Huch RA; Leo C
    Eur J Surg Oncol; 2018 Jan; 44(1):74-79. PubMed ID: 29217399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising magnetic sentinel lymph node biopsy in an in vivo porcine model.
    Ahmed M; Anninga B; Pouw JJ; Vreemann S; Peek M; Van Hemelrijck M; Pinder S; Ten Haken B; Pankhurst Q; Douek M
    Nanomedicine; 2015 May; 11(4):993-1002. PubMed ID: 25680540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of fluorescence with a magnetic tracer and dilution effect upon sentinel node localization in a murine model.
    Kuwahata A; Ahmed M; Saeki K; Chikaki S; Kaneko M; Qiu W; Xin Z; Yamaguchi S; Kaneko A; Douek M; Kusakabe M; Sekino M
    Int J Nanomedicine; 2018; 13():2427-2433. PubMed ID: 29719391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope.
    Thill M; Kurylcio A; Welter R; van Haasteren V; Grosse B; Berclaz G; Polkowski W; Hauser N
    Breast; 2014 Apr; 23(2):175-9. PubMed ID: 24484967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adapted protocol for magnetic localisation of nonpalpable breast cancer lesions and sentinel lymph nodes using a magnetic seed and superparamagnetic iron oxide tracer.
    Spiekerman van Weezelenburg MA; van Haaren ERM; Aldenhoven L; Frotscher CNA; Körver-Steeman R; van Bastelaar J; Bouwman LH; Vissers YLJ; Janssen A
    J Surg Oncol; 2023 Apr; 127(5):776-781. PubMed ID: 36598179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe.
    Taruno K; Kurita T; Kuwahata A; Yanagihara K; Enokido K; Katayose Y; Nakamura S; Takei H; Sekino M; Kusakabe M
    J Surg Oncol; 2019 Dec; 120(8):1391-1396. PubMed ID: 31667855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node localization and staging with a low-dose of superparamagnetic iron oxide (SPIO) enhanced MRI and magnetometer in patients with cutaneous melanoma of the extremity - The MAGMEN feasibility study.
    Mirzaei N; Katsarelias D; Zaar P; Jalnefjord O; Johansson I; Leonhardt H; Wärnberg F; Olofsson Bagge R
    Eur J Surg Oncol; 2022 Feb; 48(2):326-332. PubMed ID: 35000820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node mapping with superparamagnetic iron oxide for melanoma: a pilot study in healthy participants to establish an optimal MRI workflow protocol.
    Aldenhoven L; Frotscher C; Körver-Steeman R; Martens MH; Kuburic D; Janssen A; Beets GL; van Bastelaar J
    BMC Cancer; 2022 Oct; 22(1):1062. PubMed ID: 36241982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine model.
    Pouw JJ; Ahmed M; Anninga B; Schuurman K; Pinder SE; Van Hemelrijck M; Pankhurst QA; Douek M; Ten Haken B
    Int J Nanomedicine; 2015; 10():1235-43. PubMed ID: 25709445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model.
    Anninga B; Ahmed M; Van Hemelrijck M; Pouw J; Westbroek D; Pinder S; Ten Haken B; Pankhurst Q; Douek M
    Breast Cancer Res Treat; 2013 Aug; 141(1):33-42. PubMed ID: 23954989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer.
    Karakatsanis A; Daskalakis K; Stålberg P; Olofsson H; Andersson Y; Eriksson S; Bergkvist L; Wärnberg F
    Br J Surg; 2017 Nov; 104(12):1675-1685. PubMed ID: 28877348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo sentinel lymph node mapping in colorectal cancer using a magnetic nanoparticle tracer to improve staging accuracy: a pilot study.
    Pouw JJ; Grootendorst MR; Klaase JM; van Baarlen J; Ten Haken B
    Colorectal Dis; 2016 Dec; 18(12):1147-1153. PubMed ID: 27218666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.
    Hersi AF; Eriksson S; Ramos J; Abdsaleh S; Wärnberg F; Karakatsanis A
    Eur J Surg Oncol; 2019 Apr; 45(4):544-549. PubMed ID: 30401506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.